Immatics Stock (NASDAQ: IMTX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 324.78K |
Day Range | - - - |
52 Wk Range | 7.15 - 13.77 |
Market Cap | $1.24B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 54 |
Short Interest | 12.78% |
Days to Cover | 36.28 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immatics (NASDAQ:IMTX) through any online brokerage.
Other companies in Immatics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Cogent Biosciences (NASDAQ:COGT), Arcutis Biotherapeutics (NASDAQ:ARQT) and Prothena Corp (NASDAQ:PRTA).
Immatics has a consensus price target of $22.33.
The stock price for Immatics (NASDAQ: IMTX) is $12.08 last updated September 20, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Immatics.
Immatics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Immatics.
Immatics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.